by
Gus Iversen, Editor in Chief | April 22, 2026
The Milan-based Bracco Imaging has entered a multiyear research agreement with NYU Langone Health to collaborate on the development of diagnostic imaging technologies across several modalities, the organizations said Monday.
The agreement, structured as a master research arrangement, is intended to support joint work in MR imaging, photon-counting CT, ultrasound and PET/CT, with a focus on improving clinical application and workflow integration. The collaboration will also include efforts in artificial intelligence for image analysis.
Both organizations said the partnership will combine Bracco’s experience in contrast agents and imaging products with NYU Langone’s clinical and academic research capabilities. The work is expected to span both early-stage research and efforts to translate findings into clinical practice.
Ad Statistics
Times Displayed: 346433
Times Visited: 21062 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
“The agreement reflects a shared commitment between the Bracco Group and NYU Langone Health to advance research and clinical innovation in medical imaging,” said Fulvio Renoldi Bracco, vice chairman and CEO of Bracco Imaging. “By combining our respective strengths, we aim to further enhance diagnostic performance, streamline clinical workflows and ultimately generate meaningful impact for patients and healthcare systems.”
Dr. Michael P. Recht, Louis Marx professor of radiology and chair of the department of radiology at NYU Grossman School of Medicine, said the collaboration reflects broader trends in imaging research.
“Diagnostic imaging is advancing at a remarkable pace, and strategic collaborations are essential to progress,” Recht said. “We are excited to build on NYU Langone Health’s legacy of advances, and to work with the Bracco Group toward breakthroughs in modalities central to precision medicine in terms of superior diagnostic accuracy and enhanced clinical decision-making.”
The agreement does not disclose financial terms or specific project timelines. Bracco Imaging develops contrast agents and diagnostic imaging products across X-ray, CT, MR and ultrasound, while NYU Langone operates an academic health system with a large imaging research program.
